FibroSIGHT™ Plus: Precision in Fibrosis Assessment with AI-based Analysis

AI and digital-based pathology corroborate reduction in fibrosis observed by conventional pathology with efruxifermin treatment of patients with F2-F3 MASH in the HARMONY study